Global Pain Management Drugs Market
Pain management drugs are defined as specific drug classes that have pharmacological actions on pain receptors & work against the pain symptoms. These drugs can be used for pain management of conditions, as indicated on label & some drugs have off-label uses. For example, antidepressants & anticonvulsants were originally used for the management of depression & epilepsy respectively. However, these drugs have shown activity against pain indications & are prescribed for pain management as off-label indication.
Market Drivers
Growing geriatric population is the main factor which drives global pain management drugs market growth, as geriatric people are more to suffer from joint as well as other chronic conditions. Also, the increase in prevalence of chronic diseases like diabetes, cancer, and osteoarthritis will positively influence the market growth. In addition, the increase in number of surgical procedures and growing healthcare expenditure are expected to propel the global pain management drugs market growth.
Furthermore, lack of alternative treatment therapies is expected to boost the target market growth throughout the forecast period. For instance, in 2015, Depomed, Inc. has acquired the United States rights to NUCYNTA ER (tapentadol), NUCYNTA (tapentadol), extended-release tablets & NUCYNTA (tapentadol) oral solution from Janssen Pharmaceuticals, Tapentadol is available in solution, tablet, and extended-release forms. Moreover, the solution & tablet forms of NUCYNTA have three patents, out of which one expired in the June 2017 and remaining two will expire in June 2025 & August 2029, respectively. Moreover, patent expiry of pain management drugs like Oxycontin, Opana, Celebrex (2013 - 2014), and others are creating opportunity to key players for introducing new products in the market.
Market Restraints
Life threatening side effects associated with pain management medications & addiction issues with opioid drugs are expected to hamper the global pain management drugs market growth over the forecast period. Also, lack of research and development activities by major players are anticipated to hinder global pain management market growth.
Impact of COVID-19
The COVID-19 crisis is expected to impact the pain management drugs market in the initial phase of over the forecast period. The pandemic has stressed healthcare systems across the globe, so many clinics & pain services are no longer open for public services, due to safety measures imposed by governments. Also, during the latter half of the forecast period, demand for pain management drugs is expected to increase, owing to numerous factors including telemedicine, which is an appropriate & effective way to provide necessary medical services to patients with chronic pain.
Market Segmentation
The global pain management market is segmented into pain type such as Acute, and Chronic, by drug class such as NSAIDs, Anticonvulsants, Anesthetics, Antidepressants, Anti-migraine Agents, Opioids, and Nonnarcotic Analgesics. Further, market is segmented into indication such as Arthritic Pain, Neuropathic Pain, Chronic Back Pain, Postoperative Pain, Migraine, Muscle sprain/strain, Acute appendicitis, and Others.
Also, the Global Pain Management Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Regional Analysis
The North America region accounted for majority of pain management drug market share in the year 2019, and it is anticipated to remain dominant over the forecast period. Due to the increase in geriatric population and favorable regulatory conditions. The increase in number of drug abuse cases & additive nature of opioid has reduced use of prescriptions for opioid in the region. Moreover, the APAC region is expected to experience highest growth rate throughout the forecast period, due to presence of larger patient pool and the rise in healthcare experience in the region.
Market Key Players
Various key operating players are listed in this report such as Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions, Inc., Pfizer, Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., Purdue Pharma L.P., Mylan NV., etc.
Market Taxonomy
By Pain Type
By Drug Class
By Indication
By Region
Key Questions Addressed by the Report
Global Pain Management Drugs Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Pain Management Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Pain Management Drugs Market, By Pain Type
5.1 Y-o-Y Growth Comparison, By Pain Type
5.2 Global Pain Management Drugs Market Share Analysis, By Pain Type
5.3 Global Pain Management Drugs Market Size and Forecast, By Pain Type
5.3.1Acute
5.3.2. Chronic
6 Global Pain Management Drugs Market, By Drug Class
6.1 Y-o-Y Growth Comparison, By Drug Class
6.2 Global Pain Management Drugs Market Share Analysis, By Drug Class
6.3 Global Pain Management Drugs Market Size and Forecast, By Drug Class
6.3.1Hardware
6.3.2 Pain Management Drugs Readers
6.3.3 Software
6.3.4 Services
7 Global Pain Management Drugs Market, By Indication
7.1 Y-o-Y Growth Comparison, By Indication
7.2 Global Pain Management Drugs Market Share Analysis, By Indication
7.3 Global Pain Management Drugs Market Size and Forecast, By Indication
7.3. 1 Arthritic Pain
7.3.2. Neuropathic Pain
7.3.3. Chronic Back Pain
7.3.4. Postoperative Pain
7.3.5. Migraine
7.3.6. Muscle sprain/strain
7.3.7. Acute appendicitis
7.3.8. Others
8Global Pain Management Drugs Market, By Region
8.1 Global Pain Management Drugs Market Share Analysis, By Region
8.2 Global Pain Management Drugs Market Share Analysis, By Region
8.3 Global Pain Management Drugs Market Size and Forecast, By Region
9 North America Pain Management Drugs Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Pain Management Drugs Market Share Analysis, By Pain Type
9.3 North America Pain Management Drugs Market Size and Forecast, By Drug Class
9.4 North America Pain Management Drugs Market Size and Forecast, By Indication
9.5 North America Pain Management Drugs Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropePain Management Drugs Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Pain Management Drugs Market Share Analysis, By Pain Type
10.3 Europe Pain Management Drugs Market Size and Forecast, By Drug Class
10.4 Europe Pain Management Drugs Market Size and Forecast, By Indication
10.5 Europe Pain Management Drugs Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Pain Management Drugs Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Pain Management Drugs Market Share Analysis, By Pain Type
11.3 Asia Pacific Pain Management Drugs Market Size and Forecast, By Drug Class
11.4 Asia Pacific Pain Management Drugs Market Size and Forecast, By Indication
11.5 Asia Pacific Pain Management Drugs Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Pain Management Drugs Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Pain Management Drugs Market Share Analysis, By Pain Type
12.3 Latin America Pain Management Drugs Market Size and Forecast, By Drug Class
12.4 Latin America Pain Management Drugs Market Size and Forecast, By Indication
12.5 Latin America Pain Management Drugs Market Size and Forecast, Country
13Middle East Pain Management Drugs Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Pain Management Drugs Market Share Analysis, By Pain Type
13.3 Middle East Pain Management Drugs Market Size and Forecast, By Drug Class
13.4 Middle East Pain Management Drugs Market Size and Forecast, By Indication
13.5 Middle East Pain Management Drugs Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Novartis AG
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Abbott Laboratories
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Eli Lilly & Company
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Endo Health Solutions, Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pfizer, Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Merck & Co. Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Johnson & Johnson
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 GlaxoSmithKline Plc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Purdue Pharma L.P
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Mylan NV
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
